乳腺MRI影像组学方法预测新辅助化疗后病理完全缓解的准确性:系统综述与网络荟萃分析
该系统综述与网络荟萃分析比较了九种预测策略(包括常规生物标志物、新辅助化疗前/中/后MRI影像组学分析、联合策略及列线图方法)在预测乳腺癌患者新辅助化疗后病理完全缓解(pCR)方面的准确性。共纳入14项研究、2722例乳腺癌的影像组学数据(其中994例用于验证队列)。结果显示,除化疗前MRI影像组学外,所有MRI衍生影像组学特征均较生物标志物提高了预测准确性;化疗中MRI和化疗后MRI分别较化疗前MRI提高了预测准确性;化疗后MRI是 extrapolate 影像组学数据预测pCR最准确的影像方法。
要点
- 化疗后MRI影像组学是预测pCR最准确的影像方法。
- 化疗中及化疗后MRI影像组学均优于化疗前MRI。
- 联合多次MRI并未比单次化疗中或化疗后MRI提高预测性能。
英文原文(摘要)· 点击展开
BACKGROUND: Achieving pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) improves survival outcomes for breast cancer patients. Currently, conventional histopathological biomarkers predicting such responses are inconsistent. Studies investigating radiomic texture analysis from breast magnetic resonance imaging (MRI) to predict pCR have varied radiomic protocols introducing heterogeneity between results. Thus, the efficacy of radiomic profiles compared to conventional strategies to predict pCR are inconclusive.
PURPOSE: Comparing the predictive accuracy of different breast MRI radiomic protocols to identify the optimal strategy in predicting pCR to NAC.
MATERIAL AND METHODS: A systematic review and network meta-analysis was performed according to PRISMA guidelines. Four databases were searched up to October 4th, 2021. Nine predictive strategies were compared, including conventional biomarker parameters, MRI radiomic analysis conducted before, during, or after NAC, combination strategies and nomographic methodology.
RESULTS: 14 studies included radiomic data from 2,722 breast cancers, of which 994 were used in validation cohorts. All MRI derived radiomic features improved predictive accuracy when compared to biomarkers, except for pre-NAC MRI radiomics (odds ratio [OR]: 0.00; 95 % CI: -0.07-0.08). During-NAC and post-NAC MRI improved predictive accuracy compared to Pre-NAC MRI (OR: 0.14, 95 % CI: 0.02-0.26) and (OR: 0.26, 95 % CI: 0.07-0.45) respectively. Combining multiple MRIs did not improve predictive performance compared to Mid- or Post-NAC MRIs individually.
CONCLUSION: Radiomic analysis of breast MRIs improve identification of patients likely to achieve a pCR to NAC. Post-NAC MRI are the most accurate imaging method to extrapolate radiomic data to predict pCR.
引用
- O'Donnell, Gasior, Davey, et al. The accuracy of breast MRI radiomic methodologies in predicting pathological complete response to neoadjuvant chemotherapy: A systematic review and network meta-analysis. Eur J Radiol. 2022. PMID: 36308849. doi:10.1016/j.ejrad.2022.110561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。